| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 150.52M | 37.59M | 176.94M | 126.36M | 27.52M | 24.49M |
| Gross Profit | 48.49M | 6.93M | 69.00M | 44.32M | 8.66M | 11.09M |
| EBITDA | 8.43M | -12.17M | 13.48M | -2.91M | -23.39M | -23.59M |
| Net Income | -20.49M | -32.02M | -20.16M | -23.77M | -44.41M | -43.26M |
Balance Sheet | ||||||
| Total Assets | 511.62M | 546.92M | 555.23M | 602.36M | 536.21M | 557.98M |
| Cash, Cash Equivalents and Short-Term Investments | 39.68M | 40.30M | 46.95M | 50.21M | 21.38M | 26.76M |
| Total Debt | 93.71M | 87.70M | 121.46M | 119.14M | 81.74M | 61.68M |
| Total Liabilities | 142.71M | 199.05M | 176.41M | 203.15M | 113.07M | 90.23M |
| Stockholders Equity | 372.33M | 351.41M | 382.16M | 402.32M | 426.08M | 470.49M |
Cash Flow | ||||||
| Free Cash Flow | 24.91M | 28.71M | 16.21M | -26.61M | -25.43M | -12.18M |
| Operating Cash Flow | 26.94M | 29.18M | 18.23M | -22.15M | -16.46M | -11.44M |
| Investing Cash Flow | -1.46M | 518.00K | -1.78M | -6.24M | -8.97M | -737.00K |
| Financing Cash Flow | -46.63M | -36.90M | -24.01M | 57.23M | 20.06M | 31.17M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | HK$368.36M | -1.14 | -4.72% | ― | 3.58% | -91.61% | |
56 Neutral | HK$635.24M | -22.90 | -0.66% | ― | 3.97% | 41.51% | |
49 Neutral | HK$271.96M | -0.16 | -19.01% | ― | -2.75% | -17.31% | |
49 Neutral | HK$157.15M | -0.82 | -4.69% | ― | 3.58% | -87.78% | |
47 Neutral | HK$399.18M | -19.71 | ― | ― | ― | ― | |
40 Neutral | HK$485.34M | -0.27 | -29.62% | ― | -0.60% | 34.74% |
Mexan Limited has issued a clarification after noting recent sharp increases in its share price and heightened press coverage related to the stake held by its controlling shareholder. Following internal enquiries, the company said it has been informed that the controlling shareholder may be considering a preliminary internal review of its shareholding in Mexan, but stressed that there is currently no information arising from this that requires disclosure under Hong Kong listing rules. The board pledged to continue observing all disclosure obligations and cautioned shareholders and potential investors to exercise care when trading the company’s securities, underscoring that any potential changes in ownership remain at an early and uncertain stage.
The most recent analyst rating on (HK:0022) stock is a Hold with a HK$0.15 price target. To see the full list of analyst forecasts on Mexan stock, see the HK:0022 Stock Forecast page.
Mexan Limited has reported its unaudited interim results for the six months ending September 30, 2025, showing significant financial improvement. The company’s revenue increased by 75% to HK$25,079,000, and it achieved a gross profit of HK$8,592,000, a substantial rise from the previous year. The profit attributable to the owners of the company surged to HK$381,746,000, marking a remarkable turnaround from the loss reported in the same period last year. This financial performance highlights Mexan’s strengthened market position and operational efficiency, indicating positive implications for stakeholders.
Mexan Limited has announced a board meeting scheduled for November 19, 2025, where the interim financial results for the six months ending September 30, 2025, will be approved. This announcement is crucial for stakeholders as it will provide insights into the company’s financial health and operational performance during this period.